Biotech

All Articles

Boehringer offers up to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is actually providing to $1.3 billion for Nerio Therapeutics and a preclinical...

Ventyx's last resort for inflammatory med ends in Crohn's breakdown

.Ventyx Biosciences' Crohn's disease medication did not aid clients achieve remission in a period 2 ...

Cognition's period 2 radiate information taint Alzheimer's possibility

.Knowledge Therapies' stage 2 luster test has actually taken some of the radiance off the Alzheimer'...

BMS axes bispecific months after submitting to run stage 3 trial

.Bristol Myers Squibb has had a whiplash change of mind on its BCMA bispecific T-cell engager, stopp...

Charles Baum takes over Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that managed Mirati Therapies' $ 5.8 billion sale to Bristol Myers Squib...

Asarina to close after initiatives to companion Tourette's drug fall short

.After communicating to more than 200 companies to companion a Tourette disorder therapy that showed...

Novartis markers $150M ahead of time bispecifics take care of Dren Bio

.Novartis has possessed some bad luck along with bispecific antibodies before, but determining by th...

AstraZeneca plants an EGFR tree with Pinetree package worth $45M

.Pinetree Rehabs are going to aid AstraZeneca vegetation some trees in its own pipeline with a new t...

GRO rounds up $60M set B to take gout treatment into center

.GRO Biosciences has ended the full week with an additional $60.3 thousand in the banking company, w...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops chief executive officer

.Welcome to this week's Chutes &amp Ladders, our roundup of notable management hirings, shootings an...